Precision Business Insights
Portfolio

 

Research Reports

Peptide API Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025

Global Peptide API Market: By Category (Biologically Active Peptides, Enzyme Inhibitors, Polypeptides, Oligopeptides, and Others), By Therapeutic Area (Cancer, Cardiovascular, Respiratory, Nervous Systems, Gastrointestinal, and Others), By End User (Biopharmaceutical Companies, Pharmaceutical Companies, Research Institutes & Universities, and Others), and Geography

 

Global Peptide API Market Report Description:

 

Global peptide API market report gives comprehensive outlook on peptide API across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report on global peptide API market gives historical, current, and future market sizes (US$ Mn) on the basis of category, therapeutic area, end user, and region. This report studies global peptide API market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global peptide API market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global peptide API market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global peptide API market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global peptide API products.

 

Global Peptide API Market:

The global peptide API market estimated to be valued US$ XX Mn in 2018 and poised to grow at significant CAGR over 2019-2025 owing to increase in scientific advancements and rising number of pharmaceutical and biopharmaceutical companies across the globe are expected to propel the growth of the market. Additionally, launch of novel technologies and strategic collaborations between the market players are expected to enhance the sales of the peptide API market. However manufacturing peptide API is a complex process that involves sophisticated technology and expert oversight are expected to hamper the growth of the market.

 

North America Holds the Highest Market Revenue Share in Global Peptide API Market

North America accounted for larger revenue share in global peptide API market with significant CAGR owing to increasing number of research activities and advancements in technologies and presence of leading market players in the region are expected to increase the growth of the market over the forecasted years. Moreover, increasing prevalence of chronic diseases such as cancer, cardiovascular and autoimmune diseases and rising focus on development of new products and drugs are expected to drive the growth of the market. Europe and Asia Pacific region are expected to grow at a significant growth rate over the forecast years.

 

Competition Assessment

Key player’s profiles in the global peptide API market include:

  • CordenPharma
  • Hemmo Pharmaceuticals Pvt Ltd.
  • Auspep (Australia)
  • BACHEM
  • BAM Biotech Company
  • CS Bio (California)
  • Almac Group
  • Tapi Teva
  • Novetide
  • Lyotex Sciences
  • Aspen Oss
  • Peptide Institute Inc.

 

Key Findings of the Report:

 

  • Global peptide API market expanding at significant CAGR over 2018 to 2024 owing to rising prevalence of chronic disorders and rising advancements in technology for the development of new products and drugs
  • Based on category, biologically active peptides segment of peptide API accounted for larger market revenue share in 2018 and projected to gain market revenue share over the forecast period
  • Players focusing on innovation of newer products and collaboration strategies to retain market position in global peptide API market

 

Detailed Segmentation

 

By Category

  • Biologically Active Peptides
  • Enzyme Inhibitors
  • Polypeptides
  • Oligopeptides
  • Others

By Therapeutic Area  

  • Cancer
  • Cardiovascular
  • Respiratory
  • Nervous Systems
  • Gastrointestinal
  • Others

By End User  

  • Biopharmaceutical Companies
  • Pharmaceutical Companies
  • Research Institutes & Universities
  • Others

Geography

 

North America

  • US
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

Asia-Pacific

  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America

Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

 

Key Features of the Report:

 

  • The report provides granular level information about the market size, regional market share, historic market (2014-2018) and forecast (2019-2025)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Table of Content

  1. Executive Summary
  2. Global Peptide API Market Introduction
    • Global Peptide API Market – Taxonomy
    • Global Peptide API Market –Definitions
      • By category
      • By Therapeutic Area
      • By End User
  1. Global Peptide API Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Peptide API Market Dynamics – Factors Impact Analysis
  2. Global Peptide API Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global Peptide API Market Forecast, By Category, 2014 – 2018 and Forecast, 2019 – 2025
    • Biologically Active Peptides
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Enzyme Inhibitors
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Polypeptides
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Oligopeptides
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Peptide API Market Forecast, By Therapeutic Area, 2014 – 2018 and Forecast, 2019 – 2025
    • Cancer
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Cardiovascular
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Respiratory
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Nervous Systems
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Gastrointestinal
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Peptide API Market Forecast, By End User, 2014 – 2018 and Forecast, 2019 – 2025
    • Biopharmaceutical Companies
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Pharmaceutical Companies
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Research Institutes & Universities
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Peptide API Market Forecast, By Region, 2014 – 2018 and Forecast, 2019 – 2025
    • North America
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia Pacific
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • The Middle East & Africa
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Peptide API Market – Opportunity Analysis Index, By Category, By Therapeutic Area, By End User, and Region, 2019 – 2025
  2. North America Peptide API Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Category Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Biologically Active Peptides
      • Enzyme Inhibitors
      • Polypeptides
      • Oligopeptides
      • Others
    • Therapeutic Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Cancer
      • Cardiovascular
      • Respiratory
      • Nervous Systems
      • Gastrointestinal
      • Others
    • End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Biopharmaceutical Companies
      • Pharmaceutical Companies
      • Research Institutes & Universities
      • Others
    • Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US.
      • Canada
    • North America Peptide API Market – Opportunity Analysis Index, By Category, By Therapeutic Area, By End User, and Country, 2019 – 2025
    • North America Peptide API Market Dynamics – Trends
  3. Europe Peptide API Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Category Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Biologically Active Peptides
      • Enzyme Inhibitors
      • Polypeptides
      • Oligopeptides
      • Others
    • Therapeutic Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Cancer
      • Cardiovascular
      • Respiratory
      • Nervous Systems
      • Gastrointestinal
      • Others
    • End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Biopharmaceutical Companies
      • Pharmaceutical Companies
      • Research Institutes & Universities
      • Others
    • Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • UK.
      • Germany
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Europe Peptide API Market – Opportunity Analysis Index, By Category, By Therapeutic Area, By End User, and Country, 2019 – 2025
    • Europe Peptide API Market Dynamics – Trends
  4. Asia Pacific Peptide API Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Category Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Biologically Active Peptides
      • Enzyme Inhibitors
      • Polypeptides
      • Oligopeptides
      • Others
    • Therapeutic Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Cancer
      • Cardiovascular
      • Respiratory
      • Nervous Systems
      • Gastrointestinal
      • Others
    • End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Biopharmaceutical Companies
      • Pharmaceutical Companies
      • Research Institutes & Universities
      • Others
    • Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • China
      • Japan
      • India
      • ASEAN Counties
      • Philippines
      • Rest of Asia Pacific
    • Asia Pacific Peptide API Market – Opportunity Analysis Index, By Category, By Therapeutic Area, By End User, and Country, 2019 – 2025
    • Asia Pacific Peptide API Market Dynamics – Trends
  5. Latin America Peptide API Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Category Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Biologically Active Peptides
      • Enzyme Inhibitors
      • Polypeptides
      • Oligopeptides
      • Others
    • Therapeutic Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Cancer
      • Cardiovascular
      • Respiratory
      • Nervous Systems
      • Gastrointestinal
      • Others
    • End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Biopharmaceutical Companies
      • Pharmaceutical Companies
      • Research Institutes & Universities
      • Others
    • Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Mexico
      • Brazil
      • Argentina
      • Chile
      • Rest of Latin America
    • Latin America Peptide API Market – Opportunity Analysis Index, By Category, By Therapeutic Area, By End User, and Country, 2019 – 2025
    • Latin America Peptide API Market Dynamics – Trends
  6. Middle East and Africa Peptide API Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Category Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Biologically Active Peptides
      • Enzyme Inhibitors
      • Polypeptides
      • Oligopeptides
      • Others
    • Therapeutic Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Cancer
      • Cardiovascular
      • Respiratory
      • Nervous Systems
      • Gastrointestinal
      • Others
    • End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Biopharmaceutical Companies
      • Pharmaceutical Companies
      • Research Institutes & Universities
      • Others
    • Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • GCC Countries
      • South Africa
      • Saudi Arabia
      • Turkey
      • Rest of MEA
    • Middle East and Africa Peptide API Market – Opportunity Analysis Index, By Category, By Therapeutic Area, By End User, and Country, 2019 – 2025
    • Middle East and Africa Peptide API Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Key Developments, Strategies, and SWOT Analysis)
      • CordenPharma
      • Hemmo Pharmaceuticals Pvt Ltd.
      • Auspep (Australia)
      • BACHEM
      • BAM Biotech Company
      • CS Bio (California)
      • Almac Group
      • Tapi Teva
      • Novetide
      • Lyotex Sciences
      • Aspen Oss
      • Peptide Institute Inc.
  1. Research Methodology

     16. Key Assumptions and Acronyms

$ 3,000.00$ 8,900.00
Clear selection

Select License Type

Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner
FacebookTwitterLinkedinEmail

Our Clients

Testimonials